Grantham, Mayo, Van Otterloo & Co (GMO)’s Rentokil RTO Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$680K	Hold	21,600	–	–	﹤0.01%	539
2025 Q4	$636K	Sell	21,600 -24,700	-53%	-$686K	﹤0.01%	559
2025 Q3	$1.17M	Hold	46,300	–	–	﹤0.01%	459
2025 Q2	$1.11M	Buy	+46,300	New	+$1.07M	﹤0.01%	466

Other funds holding RTO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Summitry LLC Foster City, California $2.83B AUM 17.32% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s RTO Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) held its Rentokil (RTO) position steady in Q1 2026 at 21,600 shares worth $680K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in RTO in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.17M in Q3 2025. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

Grantham, Mayo, Van Otterloo & Co (GMO) held 21,600 shares of Rentokil worth $680K as of Q1 2026.
Grantham, Mayo, Van Otterloo & Co (GMO) left its Rentokil share count unchanged in Q1 2026.
Rentokil made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #539 holding.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Rentokil in Q2 2025 and has held it in 4 quarters since.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Rentokil position peaked at $1.17M in Q3 2025.
282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.